Latest Insider Transactions at Sana Biotechnology, Inc. (SANA)
This section provides a real-time view of insider transactions for Sana Biotechnology, Inc. (SANA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sana Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sana Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2021
|
Robert Nelsen |
BUY
Other acquisition or disposition
|
Indirect |
12,500
+50.0%
|
-
|
|
Apr 14
2021
|
Steve Harr President & CEO |
SELL
Bona fide gift
|
Direct |
334,000
-2.06%
|
-
|
|
Feb 08
2021
|
James J. Mac Donald EVP & General Counsel |
BUY
Conversion of derivative security
|
Indirect |
7,812
+50.0%
|
-
|
|
Feb 08
2021
|
James J. Mac Donald EVP & General Counsel |
BUY
Conversion of derivative security
|
Direct |
93,750
+17.94%
|
-
|
|
Feb 08
2021
|
Geoffrey Von Maltzahn Director |
BUY
Conversion of derivative security
|
Indirect |
366,122
+50.0%
|
-
|
|
Feb 08
2021
|
Geoffrey Von Maltzahn Director |
BUY
Conversion of derivative security
|
Direct |
1,464,488
+50.0%
|
-
|
|
Feb 08
2021
|
Steve Harr President & CEO |
BUY
Conversion of derivative security
|
Direct |
2,031,250
+19.9%
|
-
|
|
Feb 08
2021
|
Robert Nelsen |
BUY
Conversion of derivative security
|
Indirect |
43,750,000
+49.82%
|
-
|
|
Feb 08
2021
|
Hans Edgar Bishop |
BUY
Conversion of derivative security
|
Direct |
2,031,250
+26.15%
|
-
|
|
Feb 08
2021
|
Arch Venture Fund X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
87,500,000
+49.82%
|
-
|
|
Feb 08
2021
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
34,239,018
+50.0%
|
-
|
|
Feb 03
2021
|
Joshua H. Bilenker |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$500,000
$25.0 P/Share
|